Hospital Hm Nou Delfos — Clinical Trial Site

88 Registered trials

48 Currently recruiting

Organisation

Hospital Hm Nou Delfos

Location

Barcelona, Spain

Identifier

ORG-100043350

Address

Avinguda De Vallcarca 151, 08023, Spain

Departments

#3303: Oncology
#7003;Medical Oncology
#E3032402: N/A
3303: Oncologia
608 : Oncología
7002: CIOCC Early Phase
9410:Oncología
Early Phase Unit
Ensayos Clinicos Fases I START
ESP01-0: Oncologia Médica
Infectius diseases
Medical Oncology
Medical Oncology Department
Medical Oncology service
N/A
Neurology Service
Not applicable
Oncología
Oncologia Medica
Oncologia, Ensayos Clinicos Fases I START-Barcelona
Oncology
Oncology Department
Oncology Service
Oncology START Barcelona – HM Nou Delfos
START
START Barcelona
START Barcelona Delfos
START Barcelona- HM Nou Delfos
START Barcelona- HM Nou Delfos,
Traumatología y cirugía ortopédica
Unidad de Ensayos Clínicos Fase 1 START.
Unidad de Ensayos Clínicos START Barcelona

Clinical trials at this site (88)

Search interface

A Phase I, Open-label, Multi-center, First-in-human Trial to Investigate E303, in Participants with Advanced Refractory Solid Tumors Under evaluation

2025-524192-24-00 advanced refractory solid tumors 1
A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralaser… Not authorised

2024-516611-24-00 Advanced solid tumour 3
A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02… Pending

2024-517339-30-00 Advanced Solid Tumors 7
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Pending

2024-518326-32-00 Patients with advanced solid malignancies that have pro 7
A clinical trial to learn about the effects of DAK539 on the blood levels of repaglinide, midazolam, drospirenone, and ethinyl estradiol in … Pending

2025-521000-22-00 Patients with advanced malignancies 3
A clinical trial to learn how liver function affects the blood levels of DAK539 in people with advanced cancer Pending

2025-521001-40-00 Advanced Malignancies and Hepatic Impairment 3
A PHASE 1/1B, OPEN-LABEL, MULTICENTER, FIRST-IN-HUMAN DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMAC… Pending

2025-522148-42-00 Advanced Solid Tumours 1
A Study of GEN1106 in Participants with Solid Tumors Pending

2025-523760-21-00 Metastatic or advanced malignant solid tumors 1
DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending

2025-523895-22-00 Non-small cell lung cancer (NSCLC) 4
A Study of YL201 in Combination with Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors Recruiting

2025-523742-27-00 Advanced solid tumors 9 2026-04-28
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting

2025-523686-15-00 Advanced or Metastatic Solid Tumors 1 2026-04-08
A Phase 1/2 First-Time-in-Human study of GSK5458514 administered alone or in combination with other anti-cancer agents in participants with … Recruiting

2025-521581-10-00 Neoplasms, Prostate 7 2026-01-16
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors Recruiting

2025-521672-60-00 Metastatic or locally advanced SST2-positive neuroendoc 7 2025-12-19
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment Recruiting

2024-517923-38-00 Newly diagnosed and/or previously treated IDH1-mutated 3 2025-12-10
A first-in-human study to learn how safe BAY 3713372 is and how it works in participants with MTAP-deleted solid tumors Recruiting

2025-520623-24-00 MTAP-deleted Solid Tumors 7 2025-11-19
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC) Recruiting

2024-517819-74-00 Pancreatic Ductal Adenocarcinoma 9 2025-06-02
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients with Selected CLDN1+ Solid Tumors Recruiting

2024-515459-39-00 Advanced or Metastatic Squamous Solid Tumors 7 2025-05-08
A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies Recruiting

2023-508805-26-00 patients with active brain metastases, where the primar 1 2024-10-23
Clinical trial of MDNA11 (investigational drug) administered alone or in combination with pembrolizumab (immune checkpoint inhibitor) in Pat… Recruiting

2023-507536-21-00 Advanced Solid Tumors 7 2024-10-04
A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications Recruiting

2023-506227-29-00 locally advanced or metastatic solid tumors 3 2024-08-30
A phase I, multicentre, open-label, dose escalation study to determine the safety and preliminary efficacy of MBS8(1V270) administered intra… Recruiting

2024-512294-26-00 Advanced solid tumors 1 2024-04-10
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors Recruiting

2022-500508-23-00 Advanced solid tumors 1 2022-10-28
A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects with Advanced KRA… Recruiting

2024-512515-45-01 Non-Small Cell Lung Cancer 1 2026-04-10
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors Recruiting

2025-523931-21-00 Advanced Malignant Solid Tumors 1 2026-04-07